Dr. Dongming Sun, Assistant Director, W. M. Keck Center for Collaborative Neuroscience and assistant research professor at Rutgers, The State University of New Jersey is an investigator in the field of spinal cord injury research. Dr. Sun graduated from Beijing Medical University, obtained a Ph.D. from Columbia University, and joined the W. M. Keck Center for Collaborative Neuroscience in 2000.
Dr. Sun worked on cytoskeleton proteins both as a graduate student and as a postdoctoral fellow at Columbia University. He was involved in the characterization of neurofilament triplet proteins assembly, phosphorylation, and axonal movement. Dr. Sun also is involved in the identification of microtubule actin cross-linking factor (MACF), a new family of cytoskeleton crosslink proteins.
In 2000, Dr. Sun was recruited to W. M. Keck Center for Collaborative Neuroscience to develop therapies for spinal cord injury and to oversee laboratory operations. He has received grants from the New Jersey Commission on Spinal Cord Research to investigate activated macrophage transplantation as a potential therapy for spinal cord injury and to develop a mouse spinal cord contusion model for the MASCIS impactor. He also is collaborating with other research institutions and the private sector to develop and test new therapies for the treatment of spinal cord injuries. Dr. Sun currently is directing research in the development of human umbilical cord blood stem cell treatments for spinal cord injured patients and is a primary advisor to several undergraduate students.